SILVERARC CAPITAL MANAGEMENT, LLC NBIX Holdings History
SILVERARC CAPITAL MANAGEMENT, LLC's Neurocrine Biosciences Inc Holding Summary
As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 72,583.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $8.03 Mil. This investment constitutes 1.64% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0.07% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2022Q1. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 2 purchases of NBIX, at an average price of $117.43, for a total of 93,065.00 shares. In addition, there have been 1 sales at an average price of $92.32 for 20,482.00 shares. Based on historical transaction data and NBIX's current price of $132.02, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his NBIX holdings is $544,485.34, reflecting a 4.98% gain to date.
SILVERARC CAPITAL MANAGEMENT, LLC NBIX ($132.02) Holding Chart
SILVERARC CAPITAL MANAGEMENT, LLC NBIX ($132.02) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
